Dear colleague,

The PPH Butterfly: First aid for post-partum haemorrhage.

We are pleased to invite you to an upcoming webinar on the PPH Butterfly scheduled for 27th June 2024 at 14:00 – 16:00 BST.

Post-partum haemorrhage (PPH) is the single biggest killer of new mothers worldwide. Around 70,000 women die from a PPH every year – that’s one every seven minutes. Whilst there are medications available for treatment, a simple and effective first aid measure is needed to immediately halt the blood flow. Until now, there has been nothing that can do this.

The PPH Butterfly (PPHB) has been developed by Professor Andrew Weeks and the team at Sanyu Research as a complete PPH management tool. It simultaneously diagnoses the source of the bleeding and provides instant treatment without the need for medicines. Although it uses the principles of traditional bimanual compression, the way that pressure is put on the uterus is less invasive, provides dignity to the mother, and can be sustained by the doctor or midwife for up to 30 minutes. If the bleeding continues despite compression, then it is likely that the bleeding is coming from a genital tract tear and attention rapidly turned to its repair.

In clinical trials, 85% of doctors felt that it assisted with their management of the PPH, and 100% of women wanted the device used again if they had another PPH.

Two clinical studies have been completed testing this device, both funded by the NIHR Invention for Innovation (i4i) programme and sponsored by the University of Liverpool. At the webinar the study team will present the results for the PPH Butterfly to date and discuss the next steps.

AGENDA

2pm BST – Welcome and introduction (Professor Andrew Weeks)

2.05 – The WHO PPH Roadmap: PPH Innovation pathway (15m+5m Q&A; Ms Mariana Widmer)

2.25 – PPH Butterfly video

2.30 – Development of the PPH Butterfly device (10m+5m Q&A; Andrew Weeks)

2.45 – Clinical outcomes of the PPH Butterfly trial (8m+2m Q&A; Ms Caroline Cunningham)

2.55 – Qualitative Outcomes of the clinical trial (8m+2m Q&A; Professor Dame Tina Lavender)

3.05 – Health Economic outcomes of the clinical trial (8m+2m Q&A; Professor Rhiannon Tudor Edwards)

3.15 – Panel Discussion (Professor Jim Thornton, Dr Suellen Miller, Dr Sam Ononge, Dr Yana Richens)

3.55 – Close (Professor Andrew Weeks)

We would highly appreciate if you could please share with anyone you feel would be interested or benefit from this webinar. Registration details to follow.

Best wishes,

 

Professor Andrew Weeks
PPH Butterfly Chief Investigator